Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the partnership, the compamies aims to develop the first circular RNA-based anticancer drug in South Korea using its next-generation mRNA therapy technology.
Lead Product(s): Circular RNA-based Drug
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: GenScript ProBio
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 09, 2023